The role of the intestinal microbiota in type 1 diabetes mellitus

scientific article published on 4 January 2016

The role of the intestinal microbiota in type 1 diabetes mellitus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/NRENDO.2015.218
P698PubMed publication ID26729037

P50authorHeli SiljanderQ40817740
Mikael KnipQ47161413
P2860cites workMetabolic reconstruction for metagenomic data and its application to the human microbiomeQ21092513
Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiomeQ21132451
CAMERA: a community resource for metagenomicsQ21145892
The metagenomics RAST server - a public resource for the automatic phylogenetic and functional analysis of metagenomesQ21284200
The COG database: an updated version includes eukaryotesQ21284294
SmashCommunity: a metagenomic annotation and analysis toolQ24489693
Enterotypes of the human gut microbiomeQ24489818
Metagenomic microbial community profiling using unique clade-specific marker genesQ24599864
Human gut microbiome viewed across age and geographyQ24602950
Linking long-term dietary patterns with gut microbial enterotypesQ24609914
QIIME allows analysis of high-throughput community sequencing dataQ24616873
A human gut microbial gene catalogue established by metagenomic sequencingQ24618931
The Pfam protein families databaseQ24619716
Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesisQ24620719
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural AfricaQ24622141
Toward defining the autoimmune microbiome for type 1 diabetesQ24629032
KEGG for representation and analysis of molecular networks involving diseases and drugsQ24644514
The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunityQ24645048
Innate immunity and intestinal microbiota in the development of Type 1 diabetesQ24647312
Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communitiesQ24647611
The Carbohydrate-Active EnZymes database (CAZy): an expert resource for GlycogenomicsQ24655377
De novo assembly of human genomes with massively parallel short read sequencingQ24655711
Velvet: algorithms for de novo short read assembly using de Bruijn graphsQ24657623
MEGAN analysis of metagenomic dataQ24673516
SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARBQ24685829
Breastfeeding and allergy: the evidenceQ26822025
Infant nutrition and later health: a review of current evidenceQ26822415
Human milk composition: nutrients and bioactive factorsQ26822855
Type 1 diabetesQ27000491
Interactions between the microbiota and the immune systemQ27028155
Utilizing novel diversity estimators to quantify multiple dimensions of microbial biodiversity across domainsQ27496201
Effect of barrier microbes on organ-based inflammationQ27693228
Diversity, stability and resilience of the human gut microbiotaQ28274959
Environmental triggers and determinants of type 1 diabetesQ28283357
Development of intestinal microbiota in infants and its impact on healthQ28283698
Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humansQ36248024
ConStrains identifies microbial strains in metagenomic datasetsQ36364571
MetaVelvet: an extension of Velvet assembler to de novo metagenome assembly from short sequence readsQ36368703
Host remodeling of the gut microbiome and metabolic changes during pregnancyQ36421887
Xenobiotics shape the physiology and gene expression of the active human gut microbiomeQ36554412
Fecal microbiota composition differs between children with β-cell autoimmunity and those withoutQ36720600
A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tractQ36830447
Gender bias in autoimmunity is influenced by microbiota.Q37294725
Fecal microbiota imbalance in Mexican children with type 1 diabetesQ37501593
Modeling the impact of antibiotic exposure on human microbiotaQ37629657
Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice.Q37664261
Development of the human gastrointestinal microbiota and insights from high-throughput sequencingQ37870427
Is the origin of type 1 diabetes in the gut?Q37980043
Techniques used to characterize the gut microbiota: a guide for the clinician.Q37997281
The 'Hygiene hypothesis' and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and FinlandQ38057812
Meta'omic analytic techniques for studying the intestinal microbiomeQ38184190
The role of infant nutrition in the prevention of future disease.Q38237658
Removal of Bovine Insulin From Cow's Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot StudyQ38475105
The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis?Q41326181
Vertical mother-neonate transfer of maternal gut bacteria via breastfeedingQ42618067
Taxonomic metagenome sequence assignment with structured output modelsQ42790557
Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.Q43067512
Pathogenesis of type 1 diabetes: implications for incidence trendsQ43791624
The Environmental Determinants of Diabetes in the Young (TEDDY) study: study designQ45185347
Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic miceQ46787541
Compromised gut microbiota networks in children with anti-islet cell autoimmunityQ46922105
High temporal and inter-individual variation detected in the human ileal microbiotaQ48064015
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.Q48516420
The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life.Q51221306
Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse.Q51369994
A maternal gluten-free diet reduces inflammation and diabetes incidence in the offspring of NOD mice.Q53059497
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.Q54468190
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.Q55066037
Sex differences in autoimmune diseaseQ55970264
Incidence of Type 1 Diabetes in FinlandQ56637647
Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhoodQ56968869
Standard of hygiene and immune adaptation in newborn infantsQ57197922
Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic miceQ57782997
Altered early infant gut microbiota in children developing allergy up to 5 years of ageQ58590854
Potential role of the intestinal microbiota of the mother in neonatal immune educationQ61940998
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic riskQ62587873
Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouseQ68153040
Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohortQ73795603
Genetic control of diabetes progressionQ74045636
The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention StudyQ74619069
Influence of mother's intestinal microbiota on gut colonization in the infantQ85064465
The impact of perinatal immune development on mucosal homeostasis and chronic inflammationQ95421092
The gut microbiota--masters of host development and physiologyQ28286102
From lifetime to evolution: timescales of human gut microbiota adaptationQ28652725
Bacterial community comparisons by taxonomy-supervised analysis independent of sequence alignment and clusteringQ28740773
Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARBQ29547254
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newbornsQ29547261
Bacterial community variation in human body habitats across space and timeQ29547432
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequencesQ29615050
Environmental biodiversity, human microbiota, and allergy are interrelatedQ30052290
Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean sectionQ30221761
Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.Q30763625
Exposure to environmental microorganisms and childhood asthmaQ31000265
Cohabiting family members share microbiota with one another and with their dogsQ31115660
IMG/M: a data management and analysis system for metagenomesQ31132895
Cesarean delivery may affect the early biodiversity of intestinal bacteriaQ33361901
Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adultsQ33464636
Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primersQ33497510
Developmental microbial ecology of the neonatal gastrointestinal tractQ33610632
Relating the metatranscriptome and metagenome of the human gut.Q33730723
Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20.Q33786301
The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditionsQ33833767
The methylome of the gut microbiome: disparate Dam methylation patterns in intestinal Bacteroides doreiQ33914240
Comparison of the gut microbiotas of healthy adult twins living in South Korea and the United StatesQ34004511
Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetesQ34063601
Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet changeQ34082845
The 'hygiene hypothesis' for autoimmune and allergic diseases: an updateQ34111851
Diabetes and genderQ34155817
Compositional and functional features of the gastrointestinal microbiome and their effects on human healthQ34274976
Optimizing read mapping to reference genomes to determine composition and species prevalence in microbial communitiesQ34311700
Evaluation of 16S rDNA-based community profiling for human microbiome researchQ34312366
Gut metagenome in European women with normal, impaired and diabetic glucose controlQ34347521
The function of our microbiota: who is out there and what do they do?Q34392557
Groundtruthing next-gen sequencing for microbial ecology-biases and errors in community structure estimates from PCR amplicon pyrosequencingQ34412286
Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional studyQ34431258
MOCAT: a metagenomics assembly and gene prediction toolkitQ34452175
The gut microbiota modulates glycaemic control and serum metabolite profiles in non-obese diabetic miceQ34497283
Dietary Intervention in Infancy and Later Signs of Beta-Cell AutoimmunityQ34567034
FANTOM: Functional and taxonomic analysis of metagenomesQ34572424
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control studyQ34596660
Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetesQ34668698
Human milk glycobiome and its impact on the infant gastrointestinal microbiotaQ34714658
Meta-analyses of studies of the human microbiotaQ34824829
Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetesQ34996838
Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET studyQ35043312
Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice.Q35105043
The intestinal microbiome in type 1 diabetesQ35120481
Long term effect of gut microbiota transfer on diabetes developmentQ35157830
The gut microbiota and its role in the development of allergic disease: a wider perspectiveQ35158619
The placenta harbors a unique microbiomeQ35171983
Aberrant gut microbiota composition at the onset of type 1 diabetes in young childrenQ35188386
Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in miceQ35192585
The impact of microbiota on brain and behavior: mechanisms & therapeutic potentialQ35201615
Fermentable fibres condition colon microbiota and promote diabetogenesis in NOD mice.Q35207919
Conducting a microbiome studyQ35208886
The small intestine microbiota, nutritional modulation and relevance for healthQ35325485
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY studyQ35371094
Peritoneal cavity is a route for gut-derived microbial signals to promote autoimmunity in non-obese diabetic miceQ35437815
The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapiesQ35539468
The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetesQ35557877
Helsinki alert of biodiversity and healthQ35612185
Sequencing and beyond: integrating molecular 'omics' for microbial community profilingQ35615383
Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 DiabetesQ35661927
Animal models have little to teach us about type 1 diabetes: 1. In support of this proposalQ35920996
P433issue3
P407language of work or nameEnglishQ1860
P921main subjecttype-1 diabetesQ124407
P304page(s)154-167
P577publication date2016-01-04
P1433published inNature Reviews EndocrinologyQ2079257
P1476titleThe role of the intestinal microbiota in type 1 diabetes mellitus
P478volume12

Reverse relations

cites work (P2860)
Q104111154A bioengineering perspective on modelling the intestinal epithelial physiology in vitro
Q36898152A microfluidics-based in vitro model of the gastrointestinal human-microbe interface
Q41836455Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial
Q46734564Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis
Q46451309Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State
Q36277657Antibiotics, gut microbiota, environment in early life and type 1 diabetes.
Q47603984Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity
Q61806595Association of prevalent vaginal microbiome of mother with occurrence of type I diabetes in child
Q97425095Bioinspired oral delivery of gut microbiota by self-coating with biofilms
Q92132360Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment
Q40067457Bone Remodeling and the Microbiome.
Q60950163Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes
Q89737539Changes in Intestinal Microbiota Are Associated with Islet Function in a Mouse Model of Dietary Vitamin A Deficiency
Q92833857Circulating metabolites in progression to islet autoimmunity and type 1 diabetes
Q89529414Controversial Roles of Gut Microbiota-Derived Short-Chain Fatty Acids (SCFAs) on Pancreatic β-Cell Growth and Insulin Secretion
Q61812173Cord-Blood Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes
Q39427195Diabetes-induced mechanophysiological changes in the small intestine and colon
Q36277135Differences in gut microbiota profile between women with active lifestyle and sedentary women.
Q48244211Early life origin of type 1 diabetes
Q33854613Early prediction of autoimmune (type 1) diabetes
Q26741457Effect of Associated Autoimmune Diseases on Type 1 Diabetes Mellitus Incidence and Metabolic Control in Children and Adolescents
Q51736799Elevated Fecal pH Indicates a Profound Change in the Breastfed Infant Gut Microbiome Due to Reduction of Bifidobacterium over the Past Century.
Q90290369Environmental Factors Associated With Type 1 Diabetes
Q92154990Epigenetic Regulation in Etiology of Type 1 Diabetes Mellitus
Q58603842Evaluation of different mucosal microbiota leads to gut microbiota-based prediction of type 1 diabetes in NOD mice
Q40132867Fatty is not that bad: feeding short-chain fatty acids to restrain autoimmunity
Q57006877Fiber Supplements Derived From Sugarcane Stem, Wheat Dextrin and Psyllium Husk Have Different Effects on the Human Gut Microbiota
Q92340565Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology
Q64993094Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life.
Q38932726Gnotobiotic mouse model's contribution to understanding host-pathogen interactions.
Q92702188Greening of Daycare Yards with Biodiverse Materials Affords Well-Being, Play and Environmental Relationships
Q55039606Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo.
Q51144461Gut Microbiota and Type 1 Diabetes.
Q64235692Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus
Q52643740Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders.
Q88916668Gut Microbiota: FFAR Reaching Effects on Islets
Q57136925Gut microbiome in type 1 diabetes: A comprehensive review
Q98726635Gut microbiota and diabetes: From correlation to causality and mechanism
Q58119415Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection
Q58599426Gut microbiota-derived D-serine protects against acute kidney injury
Q52632498Half-lives of PAHs and temporal microbiota changes in commonly used urban landscaping materials.
Q47385058Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective
Q47140307ISN Forefronts Symposium 2015: IgA Nephropathy, the Gut Microbiota, and Gut−Kidney Crosstalk.
Q38835088Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation
Q39095965Incidence of type 1 diabetes has doubled in Kuwaiti children 0-14 years over the last 20 years
Q38795235Infant Feeding and Risk of Type 1 Diabetes in Two Large Scandinavian Birth Cohorts
Q56525706Intestinal Dysbiosis in Autoimmune Diabetes Is Correlated With Poor Glycemic Control and Increased Interleukin-6: A Pilot Study
Q48298448Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes.
Q40127622Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children
Q38767617Intraportal islet transplantation: the impact of the liver microenvironment
Q40631825Is there a role for gut microbiota in type 1 diabetes pathogenesis?
Q92641663Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes
Q37578742MAHMI database: a comprehensive MetaHit-based resource for the study of the mechanism of action of the human microbiota
Q57116726Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy
Q39056719Measuring the diversity of the human microbiota with targeted next-generation sequencing
Q38869770Mechanisms and consequences of intestinal dysbiosis.
Q46033129Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer.
Q47396427Metabolomics reveals new metabolic perturbations in children with type 1 diabetes
Q58711688Metagenomic Approaches for Understanding New Concepts in Microbial Science
Q37733052Micro RNA-19a suppresses interleukin-10 in peripheral B cells of patients with diabetic retinopathy
Q93138379Microbiome and type 1 diabetes
Q37621587Microbiome sharing between children, livestock and household surfaces in western Kenya
Q54237931Mining the Virome for Insights into Type 1 Diabetes.
Q92650448Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice
Q46301789Modulation of Type 1 Diabetes Risk by the Intestinal Microbiome
Q47199753Old Fashioned vs. Ultra-Processed-Based Current Diets: Possible Implication in the Increased Susceptibility to Type 1 Diabetes and Celiac Disease in Childhood
Q38898139On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota
Q49627122Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells
Q50075636Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases.
Q60047622Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
Q48177243Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.
Q36243299Role of intestinal microbiota and metabolites on gut homeostasis and human diseases
Q99711430Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes
Q38951451Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour
Q37662549Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research
Q36951811Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics
Q89365112TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells
Q28078235Targeting gut microbiota: a potential promising therapy for diabetic kidney disease
Q48047320The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis
Q33577793The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies
Q55100740The Ramazzini Institute 13-week pilot study on glyphosate and Roundup administered at human-equivalent dose to Sprague Dawley rats: effects on the microbiome.
Q52315444The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into "Old" Diseases.
Q38927461The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis
Q48003839The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse
Q90168466The heterogeneous pathogenesis of type 1 diabetes mellitus
Q57807205The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
Q59358597The influence of the intestinal microbiome on vaccine responses
Q39386100The multiple pathways to autoimmunity
Q58773667Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
Q38952668Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases
Q49200196Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response
Q92982823Type 1 Diabetes: Disease Stratification
Q91622714Type 1 Diabetes: an Association Between Autoimmunity, the Dynamics of Gut Amyloid-producing E. coli and Their Phages
Q38774900Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota
Q38819625Use of antibiotics in childhood and risk of Type 1 diabetes: a population-based case-control study
Q47842162Waking up from antibiotic sleep
Q33363965Where genes meet environment-integrating the role of gut luminal contents, immunity and pancreas in type 1 diabetes